The limited efficacy of ICIs in SCLC is primarily attributed to its immunosuppressive and highly heterogeneous tumor microenvironment, characterized by inadequate infiltration of CD8+ T cells (23). This evidence concerns the gene CD8A and small cell lung carcinoma.